X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs DR. DATSONS LABS - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON DR. DATSONS LABS BIOCON /
DR. DATSONS LABS
 
P/E (TTM) x 41.9 -10.9 - View Chart
P/BV x 7.3 0.2 4,479.8% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 BIOCON    DR. DATSONS LABS
EQUITY SHARE DATA
    BIOCON
Mar-18
DR. DATSONS LABS
Mar-14
BIOCON /
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs1,188126 945.9%   
Low Rs30531 987.1%   
Sales per share (Unadj.) Rs68.7133.0 51.7%  
Earnings per share (Unadj.) Rs7.60.2 4,981.0%  
Cash flow per share (Unadj.) Rs14.06.6 211.4%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.10-  
Book value per share (Unadj.) Rs86.3128.8 67.0%  
Shares outstanding (eoy) m600.0031.66 1,895.1%   
Bonus/Rights/Conversions ISFCCB-  
Price / Sales ratio x10.90.6 1,846.1%   
Avg P/E ratio x98.9516.1 19.2%  
P/CF ratio (eoy) x53.411.8 451.2%  
Price / Book Value ratio x8.60.6 1,422.9%  
Dividend payout %13.20-   
Avg Mkt Cap Rs m447,9002,477 18,079.5%   
No. of employees `0006.1NA-   
Total wages/salary Rs m9,31156 16,626.8%   
Avg. sales/employee Rs Th6,705.8NM-  
Avg. wages/employee Rs Th1,514.2NM-  
Avg. net profit/employee Rs Th736.9NM-  
INCOME DATA
Net Sales Rs m41,2344,211 979.3%  
Other income Rs m2,06279 2,620.1%   
Total revenues Rs m43,2964,289 1,009.4%   
Gross profit Rs m8,291569 1,458.1%  
Depreciation Rs m3,851204 1,884.1%   
Interest Rs m615430 143.0%   
Profit before tax Rs m5,88713 46,354.3%   
Minority Interest Rs m2130-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5696 25,721.3%   
Profit after tax Rs m4,5315 94,395.8%  
Gross profit margin %20.113.5 148.9%  
Effective tax rate %26.748.0 55.5%   
Net profit margin %11.00.1 9,639.0%  
BALANCE SHEET DATA
Current assets Rs m41,4866,852 605.5%   
Current liabilities Rs m21,4136,711 319.1%   
Net working cap to sales %48.73.3 1,453.7%  
Current ratio x1.91.0 189.8%  
Inventory Days Days64161 39.8%  
Debtors Days Days94318 29.6%  
Net fixed assets Rs m50,6613,673 1,379.3%   
Share capital Rs m3,000317 947.6%   
"Free" reserves Rs m48,8083,761 1,297.7%   
Net worth Rs m51,8084,078 1,270.6%   
Long term debt Rs m17,8981,671 1,071.2%   
Total assets Rs m99,89712,633 790.8%  
Interest coverage x10.61.0 1,026.9%   
Debt to equity ratio x0.30.4 84.3%  
Sales to assets ratio x0.40.3 123.8%   
Return on assets %5.23.4 149.6%  
Return on equity %8.70.1 7,429.3%  
Return on capital %9.67.7 125.5%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m12,058964 1,250.8%   
Fx outflow Rs m7,348607 1,210.3%   
Net fx Rs m4,710357 1,319.7%   
CASH FLOW
From Operations Rs m6,6211,345 492.3%  
From Investments Rs m-6,840-2,256 303.2%  
From Financial Activity Rs m-2,397-1,200 199.8%  
Net Cashflow Rs m-2,612-2,111 123.8%  

Share Holding

Indian Promoters % 40.4 4.5 891.8%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 0.0 -  
FIIs % 10.7 1.4 792.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 94.1 21.1%  
Shareholders   109,995 20,807 528.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  STRIDES PHARMA SCIENCE  J.B.CHEMICALS  

Compare BIOCON With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Higher; Realty and IT Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector and IT sector.

Related Views on News

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, BIOCON LTD has posted a net profit of Rs 1 bn (up 47.2% YoY). Sales on the other hand came in at Rs 11 bn (up 20.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (4QFY18); Net Profit Up 19.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 19.8% YoY). Sales on the other hand came in at Rs 12 bn (up 25.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Mar 20, 2019 (Close)

TRACK BIOCON

BIOCON - DR. REDDYS LAB COMPARISON

COMPARE BIOCON WITH

MARKET STATS